Pfizer?s Bextra Faces Its First Lawsuit

For years, Merck has been under scrutiny for a number of drugs, most recently Vioxx. The recall of Vioxx has shares down by more than 40 percent and facing hundreds of lawsuits that could cost them billions of dollars. However, Merck is not alone in the scrutiny that this pharmaceutical company faces. Pfizer, the maker of Bextra and Celebrex, painkillers in the same family as Vioxx, is facing similar legal problems. The question being asked is whether Bextra and Celebrex increase the risk of heart attack and stroke.
Although Pfizer has avoided much of the negative publicity in newspapers and radio as compared to
Merck, the question still stands as to whether the problems with Vioxx extend to similar medicines taken by millions of consumers. Although these pha View the rest of this article